Roche to use energy from wastewater

Published: 27-Sep-2010
Manufacturing Sustainability

Aquantis to build wastewater plant at Penzberg site

Roche Diagnostics is to build an anaerobic plant for the biological pre-treatment of a partial wastewater flow at its 350,000m2 Penzberg site in Upper Bavaria, Germany. The plant, which produces energy rich biogas, will supplement an existing membrane bioreactor system.

Aquantis, a German subsidiary of Veolia Water Solutions & Technologies based in Ratingen, will build the anaerobic plant for the pharmaceutical firm.

The new system will pre-treat carbon-rich partial wastewater flows as well as biologically degradable liquid waste from the bio-technological production. A 480m3 Biobed EGSB reactor (Expanded Granular Sludge Bed) will be used for the biological treatment. In the course of this process biogas is produced, collected and processed. It will be used in a combined heat and power plant in the Penzberg site boiler house to generate both forms of energy.

The amount of electricity gained will cover more than 90% of the energy requirements of the wastewater treatment plant, and the thermal energy will be used to pre-heat the boiler feedwater of the power station. Further savings will be achieved by eliminating the upstream aerobic high-load step. Carbon dioxide emissions will be reduced by about 950 metric tons per year, substantially reducing Roche Penzberg’s carbon footprint.

Assembly of the anaerobic plant is planned for end of March 2011, with start-up in November 2011.

More than 500 Biobed reference plants have been installed worldwide, of which the Aquantis team has built 60. Roche says it chose a Biobed system because it is a proven process technology.

The Penzberg plant is one of the largest biotech centres in Europe. The site is also an important centre for development and production in healthcare diagnostics. Approximately 4,600 people are employed at the site.

  • Companies:
  • Veolia
  • Roche Group
See more

You may also like

Manufacturing

Danone invests $26.4m in infant milk facility in New Zealand

Read more
Investment will go toward a South Island spray drying plant for achieving carbon neutrality by 2021

Trending Articles

  1. APIs: Bioreactor hoists with a multipurpose twist Peter Devenny of PalPharma describes the solution for a biotech facility in Switzerland designed to handle filled bioreactors across GMP areas to produce ten metric tons of antibody per year
  2. Talking to Isofield's Stephen Morgan The cleanroom consumables market has been a very interesting landscape since the COVID-19 pandemic. Entering the sector in mid-2021, Stephen Morgan’s Isofield has been riding every twist and turn
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Selecting materials and components for cleanrooms Choosing which materials to use for a cleanroom construction is increasingly complex due to the wide variety of options now available. Jorge Nuero, Telstar, looks at key considerations for optimising cost and ensuring safety and quality
  4. Steriline Asia returns to CPHI & PMEC India with technology and process advancements Focus on sustainable innovation and regulatory alignment for the local market
  5. You need to be a subscriber to read this article.
    Click here to find out more.
    Media fill simulations Anne Connors, Regional Marketing Manager, BioMonitoring, Merck Millipore and Scott Sutton, Microbiology Network, outline the regulatory requirements for aseptic process simulation and look at some industry trends based on a recent survey

Upcoming event

CPhI Middle East

10–12 December 2024 | Conference | Riyadh, Saudi Arabia See all

You may also like

Manufacturing

Danone invests $26.4m in infant milk facility in New Zealand

Investment will go toward a South Island spray drying plant for achieving carbon neutrality by 2021
Manufacturing

A shot in the arm for membranes

James Steptoe, Veolia Water Technologies, looks at the implications of the latest European Pharmacopoeia Water for Injection Monograph
Manufacturing

Veolia Water Technologies UK merges divisions to support industry in managing water challenges

Veolia Water Technologies’ (Veolia) process water and waste water divisions have merged into a single organisation to better help organisations “rethink water”
Manufacturing

Veolia to showcase latest technologies at Lab Innovations

Experts will be on hand to discuss water purification and the technology's unique strengths, from removing large fractions of several impurities to removing one specific contaminant to extremely low levels
Manufacturing

Squaring the circle – Veolia looks at water systems for the pharma sector

The pharmaceutical industry requires water of particular qualities for different applications. Kalpesh Shah, Veolia Water Technologies, takes a 360° look at water use and supply options and overall cost efficiencies
Manufacturing

Pharmaceutical firms choose Veolia Polaris WFI and Clean Steam systems

All models can be supplied for steam or electric heating and are available as horizontal or vertical to suit installation space
Manufacturing

Pure Water for National Biosample Centre

Veolia supplies water purification equipment for NIHR’s flagship research facility
Subscribe now